|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/70 | |
| A61K 31/436 | |||
| C07D 491/00 |
| (11) | Patento numeris | 2948134 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14743123.3 |
| Europos patento paraiškos padavimo data | 2014-01-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/013066 |
| Data | 2014-01-24 |
| (87) | Numeris | WO 2014/117035 |
| Data | 2014-07-31 |
| (30) | Numeris | Data | Šalis |
| 201361756406 P | 2013-01-24 | US |
| (72) |
KASPAR, Roger L., US
SPEAKER, Tycho, US
|
| (73) |
Palvella Therapeutics, Inc.,
125 Strafford Avenue, Suite 360, Wayne, Pennsylvania 19087,
US
|
| (54) | COMPOSITIONS FOR TRANSDERMAL DELIVERY OF MTOR INHIBITORS |
| COMPOSITIONS FOR TRANSDERMAL DELIVERY OF MTOR INHIBITORS |